Given its crucial role in sperm function, DPY19L2 represents a potential therapeutic target for treating certain types of male infertility. Research is ongoing to develop methods to correct or bypass the defects caused by DPY19L2 mutations. Gene therapy and targeted molecular treatments are among the strategies being explored.
